Cours suspendu

Communiqués ESSA Pharma Inc.

Actions

EPIX

CA29668H7085

Sociétés holdings

Marché Fermé - Nasdaq 22:00:00 08/10/2025			Varia. 5j.	Varia. 1 janv.
0,2012 ^USD	-1,85%		-.--%	-

09/10/25	Alexis Bio finalise l'acquisition d'ESSA Pharma Inc. pour 5,3 millions de dollars	CI
07/10/25	Les actionnaires d'ESSA approuvent l'acquisition par XenoTherapeutics	RE

Communiqués

09/10/25	ESSA Announces Completion of Arrangement with XenoTherapeutics	AQ
25/08/25	Essa Pharma Inc. Clarifies Nasdaq Due Bill Trading for Previously Announced Cash Distribution	AQ
25/08/25	Essa Pharma Inc. Clarifies Nasdaq Due Bill Trading for Previously Announced Cash Distribution	PR
14/08/25	Essa Pharma Inc. Announces Ex-Dividend Date and Nasdaq Due Bill Trading for Previously Announced Cash Distribution	PR
13/08/25	ESSA Pharma: Fiscal Q3 Earnings Snapshot	AQ
06/08/25	Essa Pharma Inc. Announces US$80 Million Cash Distribution to Shareholders	PR
06/08/25	Essa Pharma Inc. Announces US$80 Million Cash Distribution to Shareholders	AQ
23/07/25	ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Approval of an Interim Order and Cash Distribution to Shareholders	PR
23/07/25	ESSA Pharma : Provides Update on its Application to the Supreme Court of British Columbia for Approval of an Interim Order and Cash Distribution to Shareholders	PU
08/05/25	ESSA Pharma: Fiscal Q2 Earnings Snapshot	AQ
08/05/25	ESSA Pharma Reports Financial Results for Fiscal Second Quarter Ended March 31, 2025	PR
25/03/25	ESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX	PR
24/03/25	The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX	PR
21/03/25	Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in ESSA Pharma Inc. Lawsuit - EPIX	PR
20/03/25	The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in ESSA Pharma Inc. Lawsuit - EPIX	PR
18/03/25	Investors in ESSA Pharma Inc. Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights - EPIX	PR
17/03/25	ESSA Pharma Inc. Class Action: The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX	PR
13/03/25	March 25, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against EPIX	PR
12/03/25	Levi & Korsinsky Notifies ESSA Pharma Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - EPIX	PR
10/03/25	Contact The Gross Law Firm by March 25, 2025 Deadline to Join Class Action Against ESSA Pharma Inc.(EPIX)	PR
07/03/25	ESSA Pharma Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights - EPIX	PR
06/03/25	ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS	PR
06/03/25	ESSA Pharma Inc. Class Action: The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX	PR
04/03/25	Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in ESSA Pharma Inc. Lawsuit - EPIX	PR
28/02/25	Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in ESSA Pharma Inc. Lawsuit - EPIX	PR